Strategic partnerships Recent collaborations with BrainCool and Japan Lifeline, plus a past partnership with Brainomix, indicate Wallaby Medical’s openness to strategic alliances. Leverage co-development, distribution, and market-entry opportunities to broaden reach in Asia and Europe, especially in stroke care.

Mergers and expansion Significant acquisition of Phenox and rapid growth signal capital deployment for productライン expansion and global footprint. Target distributors and regional integrators in high-stroke-incidence markets to capitalize on Wallaby’s enhanced device portfolio.

Stroke focus Wallaby Medical concentrates on stroke therapy devices, including thrombectomy components. Sales opportunities exist in hospitals and stroke centers seeking end-to-end solutions, complementing existing offerings with training and integration services.

Regulatory readiness ISO 13485 certification and a PMDA-approved product in Japan suggest mature quality systems. Position sales to hospitals and clinics that prioritize compliant, globally recognized devices, and offer regulatory support for new markets.

Growth potential Revenue in the low single-digit millions with a lean employee base indicates agility and room for channel scaling. Propose channel partnerships, reseller programs, and OEM opportunities to accelerate revenue growth while managing costs.